235 related articles for article (PubMed ID: 37495858)
21. A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
Ando M; Sato Y; Takata K; Nomoto J; Nakamura S; Ohshima K; Takeuchi T; Orita Y; Kobayashi Y; Yoshino T
PLoS One; 2013; 8(2):e56741. PubMed ID: 23418597
[TBL] [Abstract][Full Text] [Related]
22. Relationship between PPP1R15A gene polymorphism (rs611251) and Epstein-Barr virus-associated tumors.
Song Y; Liu S; Zhao Z; Zhang Y; Yang Y; Luo B
Acta Virol; 2017; 61(4):445-452. PubMed ID: 29186961
[TBL] [Abstract][Full Text] [Related]
23. EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features.
Chapman JR; Bouska AC; Zhang W; Alderuccio JP; Lossos IS; Rimsza LM; Maguire A; Yi S; Chan WC; Vega F; Song JY
Br J Haematol; 2021 Sep; 194(5):870-878. PubMed ID: 34272731
[TBL] [Abstract][Full Text] [Related]
24. TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients.
Cho J; Kim E; Yoon SE; Kim SJ; Kim WS
Cancer; 2023 May; 129(10):1502-1512. PubMed ID: 36812290
[TBL] [Abstract][Full Text] [Related]
25. Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells.
Xu JX; Zhang R; Huang DJ; Tang Y; Ping LQ; Huang BJ; Huang HQ; Busson P; Li J
Microbiol Spectr; 2023 Feb; 11(1):e0493222. PubMed ID: 36622166
[TBL] [Abstract][Full Text] [Related]
26. An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model.
Ma SD; Yu X; Mertz JE; Gumperz JE; Reinheim E; Zhou Y; Tang W; Burlingham WJ; Gulley ML; Kenney SC
J Virol; 2012 Aug; 86(15):7976-87. PubMed ID: 22623780
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing.
Motsch N; Alles J; Imig J; Zhu J; Barth S; Reineke T; Tinguely M; Cogliatti S; Dueck A; Meister G; Renner C; Grässer FA
PLoS One; 2012; 7(8):e42193. PubMed ID: 22870299
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr Virus Promotes Tumorigenicity and Worsens Hodgkin Lymphoma Prognosis by Activating JAK/STAT and NF-κB Signaling Pathways.
Alabiad MA; Said WMM; Saad RHF; Balata R; Mahmoud AA; Metwally EA; Shalaby AM; Samy W; Yehia AM; Yahia AIO; Alorini M; Abdelrahman DI
Iran J Med Sci; 2024 Feb; 49(2):88-100. PubMed ID: 38356485
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-associated primary central nervous system lymphoma in a patient with adult T-cell leukemia / lymphoma.
Amano M; Marutsuka K; Sugimoto T; Todaka T; Setoyama M
J Dermatol; 2011 Jun; 38(6):575-80. PubMed ID: 21366675
[TBL] [Abstract][Full Text] [Related]
30. Genomic landscape of Epstein-Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue.
Rea B; Liu YC; Maguire A; Soma LA; Bacon CM; Bayerl MG; Smith MH; Barrett MT; Swerdlow SH; Gibson SE
Mod Pathol; 2022 Jul; 35(7):938-945. PubMed ID: 34952945
[TBL] [Abstract][Full Text] [Related]
31. Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma.
Peng RJ; Han BW; Cai QQ; Zuo XY; Xia T; Chen JR; Feng LN; Lim JQ; Chen SW; Zeng MS; Guo YM; Li B; Xia XJ; Xia Y; Laurensia Y; Chia BKH; Huang HQ; Young KH; Lim ST; Ong CK; Zeng YX; Bei JX
Leukemia; 2019 Jun; 33(6):1451-1462. PubMed ID: 30546078
[TBL] [Abstract][Full Text] [Related]
32. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
Li C; Romero-Masters JC; Huebner S; Ohashi M; Hayes M; Bristol JA; Nelson SE; Eichelberg MR; Van Sciver N; Ranheim EA; Scott RS; Johannsen EC; Kenney SC
PLoS Pathog; 2020 Jun; 16(6):e1008590. PubMed ID: 32542010
[TBL] [Abstract][Full Text] [Related]
33. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection.
Vargas-Ayala RC; Jay A; Manara F; Maroui MA; Hernandez-Vargas H; Diederichs A; Robitaille A; Sirand C; Ceraolo MG; Romero-Medina MC; Cros MP; Cuenin C; Durand G; Le Calvez-Kelm F; Mundo L; Leoncini L; Manet E; Herceg Z; Gruffat H; Accardi R
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996097
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas.
Cingolani A; Gastaldi R; Fassone L; Pierconti F; Giancola ML; Martini M; De Luca A; Ammassari A; Mazzone C; Pescarmona E; Gaidano G; Larocca LM; Antinori A
J Clin Oncol; 2000 Oct; 18(19):3325-30. PubMed ID: 11013271
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic correlates of
Sethi TK; Kovach AE; Grover NS; Huang LC; Lee LA; Rubinstein SM; Wang Y; Morgan DS; Greer JP; Park SI; Ann Thompson-Arildsen M; Yenamandra A; Vnencak-Jones CL; Reddy NM
Leuk Lymphoma; 2019 Dec; 60(12):2880-2889. PubMed ID: 31184237
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of Epstein-Barr virus-associated primary central nervous system lymphoma due to post-transplantation lymphoproliferative disorder, with ibrutinib and third-party Epstein-Barr virus-specific T cells.
Law SC; Hoang T; O'Rourke K; Tobin JWD; Gunawardana J; Loo-Oey D; Bednarska K; Merida de Long L; Sabdia MB; Hapgood G; Blyth E; Clancy L; Hennig S; Keane C; Gandhi MK
Am J Transplant; 2021 Oct; 21(10):3465-3471. PubMed ID: 33942495
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
[TBL] [Abstract][Full Text] [Related]
38. Lessons from Epstein-Barr virus DNA detection in cerebrospinal fluid as a diagnostic tool for EBV-induced central nervous system dysfunction among HIV-positive patients.
Wang Y; Yang J; Wen Y
Biomed Pharmacother; 2022 Jan; 145():112392. PubMed ID: 34781140
[TBL] [Abstract][Full Text] [Related]
39. Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas.
Martini M; Capello D; Serraino D; Navarra A; Pierconti F; Cenci T; Gaidano G; Larocca LM
J Infect; 2007 Mar; 54(3):298-306. PubMed ID: 16784778
[TBL] [Abstract][Full Text] [Related]
40. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas.
Piccaluga PP; Navari M; De Falco G; Ambrosio MR; Lazzi S; Fuligni F; Bellan C; Rossi M; Sapienza MR; Laginestra MA; Etebari M; Rogena EA; Tumwine L; Tripodo C; Gibellini D; Consiglio J; Croce CM; Pileri SA; Leoncini L
Oncotarget; 2016 Jan; 7(1):224-40. PubMed ID: 26325594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
